Abstract
BCR-ABL1 rearrangement as a subclonal change in ETV6-RUNX1–positive B-ALL is a rare occurrence not previously reported. The prognosis of this rare subclonal change has not been determined, yet inclusion of tyrosine kinase inhibitors in treatment is ubiquitous.
Cite
CITATION STYLE
APA
Dun, K. A., Vanhaeften, R., Batt, T. J., Riley, L. A., Diano, G., & Williamson, J. (2016). BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia. Blood Advances, 1(2), 132–138. https://doi.org/10.1182/bloodadvances.2016000463
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free